Dr Reddys Laboratories (RDY) Return on Capital Employed [ROCE] (2009 - 2026)
Dr Reddys Laboratories' Return on Capital Employed [ROCE] was 7.86% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 11.04 percentage points from 18.90% a year earlier and down 1.48 percentage points from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Return on Capital Employed [ROCE] at Dr Reddys Laboratories came in at 13.68%, down 9.18 percentage points from FY2025.
- Return on Capital Employed [ROCE] shows a five-year change of -1.30 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Capital Employed [ROCE] was 22.86% in FY2025 (-3.11 pp), 25.97% in FY2024 (+1.53 pp), 24.44% in FY2023 (+8.91 pp) and 15.52% in FY2022 (+0.54 pp).
- The fiscal Q2 2027 figure marks the lowest quarterly Return on Capital Employed [ROCE] since fiscal Q2 2011.
- Compared with a year earlier, Return on Capital Employed [ROCE] has declined for 11 straight quarters, with an average year-over-year change of -5.94 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was fiscal Q4 2023 (a gain of 12.56 percentage points); the worst was fiscal Q2 2027 (a drop of 11.04 percentage points).
- Per Business Quant data, RDY's Return on Capital Employed [ROCE] in the three fiscal quarters before Q2 2027 was 9.34% (Q1 2027), 13.08% (Q4 2026) and 17.36% (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,244.63 Bn | 1,218.25 Bn | 20.46 Bn | 43.74% |
| 2 | Johnson & Johnson | 675.17 Bn | 595.03 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 516.80 Bn | 484.81 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 363.56 Bn | 326.51 Bn | 13.19 Bn | 5.33% |
| 5 | Novartis Ag | 315.26 Bn | 288.50 Bn | - | - |
| 6 | Astrazeneca | 292.48 Bn | 266.38 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 250.31 Bn | 201.96 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 209.33 Bn | 184.44 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.10 Bn | 114.45 Bn | 12.56 Bn | 11.32% |
| 10 | Dr Reddys Laboratories | 12.43 Bn | 11.77 Bn | 472.93 Mn | 7.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.86% |
| Jun 30, 2026 | 9.34% |
| Mar 31, 2026 | 13.08% |
| Dec 31, 2025 | 17.36% |
| Sep 30, 2025 | 18.90% |
| Jun 30, 2025 | 19.73% |
| Mar 31, 2025 | 20.43% |
| Dec 31, 2024 | 20.41% |
| Sep 30, 2024 | 21.79% |
| Jun 30, 2024 | 23.09% |
| Mar 31, 2024 | 23.82% |
| Dec 31, 2023 | 26.47% |
| Sep 30, 2023 | 25.50% |
| Jun 30, 2023 | 25.79% |
| Mar 31, 2023 | 27.25% |
| Dec 31, 2022 | 21.50% |
| Sep 30, 2022 | 18.30% |
| Jun 30, 2022 | 15.52% |
| Mar 31, 2022 | 14.69% |
| Dec 31, 2021 | 16.96% |
API Access
Dr Reddys Laboratories Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();